Literature DB >> 17898320

Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells.

Claudia S Wagner1, Lilian Walther-Jallow, Eva Buentke, Hans-Gustaf Ljunggren, Adnane Achour, Benedict J Chambers.   

Abstract

Human cytomegalovirus (HCMV) encodes the MHC class I-like molecule UL18, which binds with high affinity to the leukocyte Ig-like receptor-1 (LIR-1), an inhibitory receptor commonly expressed on myeloid cells and subsets of NK and T cells. The exact role of UL18 is not known, in particular in relation to its proposed role in HCMV immune escape. Given the ubiquitous expression of LIR-1 on dendritic cells (DCs), we hypothesized that UL18 may affect DC function. To study the effects of UL18 on DC, we made use of UL18 fusion proteins. We demonstrate that UL18 fusion proteins inhibit the chemotaxis of DCs. Furthermore, UL18 interfered with CD40 ligand-induced maturation of DCs, resulting in reduced allogeneic T cell proliferation. Finally, we demonstrate that UL18 proteins up-regulate the expression of the maturation marker CD83 on immature monocyte-derived DCs and induce cytokine production. The capacity of UL18 to affect the function and the phenotype of DCs suggests a novel role for this HCMV-derived protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898320     DOI: 10.1189/jlb.0307181

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  20 in total

1.  CD244 is expressed on dendritic cells and regulates their functions.

Authors:  Anna-Maria Georgoudaki; Sorosh Khodabandeh; Speranta Puiac; Catrine M Persson; Maria K Larsson; Max Lind; Oscar Hammarfjord; Tara H Nabatti; Robert P A Wallin; Ulf Yrlid; Mikael Rhen; Vinay Kumar; Benedict J Chambers
Journal:  Immunol Cell Biol       Date:  2015-02-03       Impact factor: 5.126

Review 2.  The tug-of-war between dendritic cells and human chronic viruses.

Authors:  Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

Review 3.  Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells.

Authors:  Wei Cao; Laura Bover
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

Review 4.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 5.  Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells.

Authors:  Katie J Anderson; Rachel L Allen
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

Review 6.  Human cytomegalovirus tropism for mucosal myeloid dendritic cells.

Authors:  Laura Hertel
Journal:  Rev Med Virol       Date:  2014-06-02       Impact factor: 6.989

Review 7.  Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship.

Authors:  Giada Rossini; Cristina Cerboni; Angela Santoni; Maria Paola Landini; Santo Landolfo; Deborah Gatti; Giorgio Gribaudo; Stefania Varani
Journal:  Mediators Inflamm       Date:  2012-05-31       Impact factor: 4.711

8.  Cytomegalovirus and tumors: two players for one goal-immune escape.

Authors:  Quentin Lepiller; Kashif Aziz Khan; Vincent Di Martino; Georges Herbein
Journal:  Open Virol J       Date:  2011-06-01

9.  The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection.

Authors:  Damien P Brown; Des C Jones; Katie J Anderson; Nicolas Lapaque; Robin A Buerki; John Trowsdale; Rachel L Allen
Journal:  BMC Immunol       Date:  2009-10-27       Impact factor: 3.615

Review 10.  Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.

Authors:  Sara Gredmark-Russ; Cecilia Söderberg-Nauclér
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.